Summary
Updated Aug 30, 2026
Kristian Humer is Chief Financial Officer of 4D Molecular Therapeutics, Inc. (FDMT). 2 SEC Form 4 filings on record, most recently on 11 December 2025.
Trading Pattern
InsiderAlpha's records for Kristian Humer go back to 2025: 2 primary Form 4 filings, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Kristian Humer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Kirn - $3.45M of FDMT open-market activity in the last 12 months
- Scott Bizily - $376K of FDMT open-market activity in the last 12 months
- Ashoo Gupta - $7K of FDMT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Kristian Humer?
Kristian Humer is a corporate insider, tracked as Chief Financial Officer of 4D Molecular Therapeutics, Inc. (FDMT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kristian Humer last file a Form 4?
The most recent primary Form 4 on record is dated 11 December 2025, one of 2 filings going back to 2025.
Where can I see all of Kristian Humer's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Kristian Humer and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial